Table 4.
Type of uveitis | Etiology | This study (Central India) | Singh and Gupta (North India) (n=1233) | Das and Bhattacharjee (North East India) (n=308) | Aratee and Vaidehi (Western India) (n=198) | Biswas et al (South India) (n=1273) |
---|---|---|---|---|---|---|
Anterior uveitis | 99 (47.14%) | 607 (49.23%) | 145 (47.07%) | 82 (41.4%) | 500 (39.28%) | |
Idiopathic | 37 (37.37%) | 372 (61.3%) | 66 (45.51%) | 44 (53.7%) | 293 (58.60%) | |
Specific | 62 (62.62%) | 235 (38.71%) | 79 (54.49%) | 38 (46.34%) | 207 (41.4%) | |
Spondyloarthropathy (seronegative/HLA B27+) | 15 (15.15%) | 80 (13.2%) | 34 (23.44%) | 24 (29.3%) | 43 (8.6%) | |
Fuch’s heterochromiccyclitis | 3 (3.03%) | 31 (5.1%) | 7 (4.82%) | 1 (1.2%) | 28 (5.6%) | |
JIA | 4 (4.04%) | 20 (3.3%) | - | 1 (1.2%) | 10 (2%) | |
Herpes-related | 18 (18.18%) | - | 1 (0.6%) | - | 6 (1.2%) | |
Rheumatoid arthritis | 1 (1.01%) | - | - | - | - | |
Leprosy | 2 (2.02%) | 5 (0.8%) | 1 (0.6%) | 1 (1.2%) | 3 (0.6%) | |
Traumatic | 8 (8.08%) | - | 25 (17.24%) | 3 (3.7%) | 17 (3.4%) | |
Tuberculosis | 5 (5.05%) | 48 (7.9%) | - | 4 (4.9%) | 3 (0.6%) | |
Posner-Schlossman | 1 (1.01%) | - | - | - | - | |
Lens induced | 5 (5.05%) | - | 10 (6.89%) | - | 44 (8.8%) | |
Intermediate uveitis | 67 (31.90%) | 198 (16.06%) | 40 (12.98%) | 33 (16.66%) | 222 (17.44%) | |
Idiopathic pars planitis | 52 (77.61%) | 181 (91.4%) | 31 (77.5%) | 23 (69.7%) | 213 (95.9%) | |
Specific | 15 (22.38%) | 17 (8.58%) | 9 (22.5%) | 10 (30.30%) | 9 (4.05%) | |
Tuberculosis | 10 (14.92%) | 8 (4%) | 4 (10%) | 8 (24.30%) | - | |
Sarcoidosis | 1 (1.49%) | - | 5 (12.5%) | 1 (3%) | - | |
JIA-associated | 2 (2.98%) | - | - | 1 (3%) | - | |
Toxoplasma | 2 (2.98%) | - | - | |||
Posterior uveitis | 27 (12.85%) | 247 (20.23%) | 92 (29.87%) | 41 (20.7%) | 366 (28.75%) | |
Idiopathic | 7 (25.92%) | 61 (24.7%) | 18 (19.56%) | 13 (31.7%) | 150 (40.98%) | |
Specific | 20 (74.07%) | - | 74 (80.43%) | - | 216 (59.01%) | |
Multifocal chorioditis | 5 (18.51%) | 51 (20.7%) | 4 (4.34%) | 1 (2.4%) | - | |
Serpiginous choroidopathy | 4 (14.81%) | 62 (25.1%) | 14 (15.21%) | - | 69 (18.85%) | |
Toxoplasmosis | 2 (7.4%) | 20 (8.1%) | 37 (40.21%) | 8 (19.5%) | 102 (27.87%) | |
Tuberculosis | 6 (22.22%) | 22 (8.9%) | 5 (5.43%) | 8 (19.5%) | - | |
Viral retinitis | 3 (11.11%) | - | 2 (2.17%) | 2 (4.9%) | 2 (0.55%) | |
Toxocara | - | - | 4 (4.34%) | - | 21 (5.74%) | |
Pan uveitis | 17 (8.09%) | 181 (14.68%) | 31 (10.06%) | 42 (21.2%) | 185 (14.53%) | |
Idiopathic | 5 (29.4%) | 17 (9.4%) | 10 (32.25%) | 18 (42.9%) | 95 (51.35%) | |
Specific | 12 (70.58%) | 164 (90.6%) | 21 (67.74%) | 24 (57.14%) | 90 (48.64%) | |
Tuberculosis | 4 (23.58%) | 47 (26%) | - | 9 (21.4%) | 4 (2.16%) | |
VKH | 2 (11.76%) | 44 (24.3%) | 14 (45.16%) | 6 (14.3%) | 39 (21.08%) | |
Behcet’s disease | 2 (11.76%) | - | 1 (3.2%) | - | 4 (2.16%) | |
Sarcoidosis | 1 (5.8%) | 17 (9.4%) | 9 (29.03%) | 1 (2.4%) | 21 (11.35%) | |
Toxoplasmosis | 2 (11.76%) | - | 1 (3.2%) | - | - | |
Sympathetic ophthalmia | 1 (5.88%) | 26 (14.4%) | 1 (3.2%) | 1 (2.4%) | 10 (5.41%) |
JIA: Juvenile idiopathic arthritis; VKH: Vogt kayanagi syndrome